Search

everythinglearnresearchcommunity

for

Search:↓

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

The C-allele and CC-genotype in the PTPN22 gene lower the risk of alopecia areata.

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

G allele of AR Stul polymorphism linked to higher hair loss risk, especially in white people.

Using 5-alpha reductase inhibitors may increase the risk of mild depression.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Certain variations of the HDAC9 gene can increase or decrease stroke risk in the Chinese population.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Using hair dye may slightly increase the risk of non-Hodgkin's lymphoma, especially with long-term use.

Using facial sunscreen and moisturizer may increase the risk of frontal fibrosing alopecia.

Dutasteride more effectively treats hair loss than finasteride, but may increase risk of altered libido.

Certain gut bacteria may protect against alopecia areata, while others may increase the risk.

All HPV vaccine studies should be registered and published to reduce reporting bias.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Artesunate is generally safe for severe malaria, but patients should be monitored for delayed anemia after treatment.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Genetic risk for hair loss can increase depression risk, but depression doesn't increase hair loss risk.

Eating more antioxidant-rich foods and less alcohol may help reduce hair loss.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Current treatments for alopecia show no significant long-term benefits.

Review finds no permanent solution for female hair loss.

Review determines effective, safe treatments for female hair loss.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

Finasteride may reduce bleeding after TURP, but more research needed.

Low levels of vitamin B12, ferritin, and calcium are linked to premature graying of hair.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.